학술논문
Correction: The CDK7 inhibitor CT7001 (Samuraciclib) targets proliferation pathways to inhibit advanced prostate cancer (British Journal of Cancer, (2023), 128, 12, (2326-2337), 10.1038/s41416-023-02252-8)
Document Type
Erratum
Author
Source
In: British Journal of Cancer . (British Journal of Cancer, 23 March 2024, 130(5):892)
Subject
Language
English
ISSN
15321827
00070920
00070920